American Journal of Ophthalmology AJO 02 91 R 1 revised Page 22
22
Freeman, Cataract Surgery and Age-Related Macular Degeneration
Table 3. Age and race-specific prevalence rates for late AMD in at least 1 eye for study
populations.
Age Strata
SEE
Whites
N (%)
BES
Whites
N (%)
PVER
Hispanics
N (%)
SEE
Blacks
N (%)
BES
Blacks
N (%)
40-49
years
NA 0/478
(0.0)
3/1587(0.2) NA 1/536
(0.2)
50-59
years
NA 4/539
(0.7)
7/1357(0.5) NA 2/544
(0.4)
60-64 years NA
2/373 (0.5) 1/518 (0.2) NA
2/244 (0.8)
65-69 years 9/521 (1.7) 4/377 (1.1) 7/463 (1.5) 4/214 (1.9)
1/204 (0.5)
>=70 years 50/1254 (4.0) 29/508 (5.7) 34/827(4.1) 5/400 (1.4)
1/218 (0.5)
Overall 59/1775
(3.3%)
39/2275
(1.7%)
52/4752
(1.1%)
9/614
(1.5%)
7/1746
(0.4%)
*Late AMD defined as choroidal neovascularization, geographic atrophy, or as a cause of blindness as
determined by photographs in SEE and BES, and by clinical exam in PVER.
Abbreviations
SEE: Salisbury Eye Evaluation
PVER: Proyecto VER
BES: Baltimore Eye Survey
NA: Not applicable
N: Number
